| 000 | 01425 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515011139.0 | ||
| 264 | 0 | _c20060118 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1530-9932 | ||
| 024 | 7 |
_a10.1208/pt060114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaboota, Sanjula | |
| 245 | 0 | 0 |
_aPhysicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note. _h[electronic resource] |
| 260 |
_bAAPS PharmSciTech _cSep 2005 |
||
| 300 |
_aE83-90 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aChemistry, Physical |
| 650 | 0 | 4 |
_aLactones _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSolubility _xdrug effects |
| 650 | 0 | 4 |
_aStomach Ulcer _xchemically induced |
| 650 | 0 | 4 |
_aSulfones _xadverse effects |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_abeta-Cyclodextrins _xadverse effects |
| 700 | 1 | _aDhaliwal, Mona | |
| 700 | 1 | _aKohli, Kanchan | |
| 773 | 0 |
_tAAPS PharmSciTech _gvol. 6 _gno. 1 _gp. E83-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1208/pt060114 _zAvailable from publisher's website |
| 999 |
_c15974412 _d15974412 |
||